短效硝苯地平片对重度血压增高的脑出血治疗观察  

Clinical efficacy of short-acting nifedipine tablets in cerebral hemorrhage patients with severely increased blood pressure

作　　者：李莉[1] 

机构地区：[1]云南省昆明市第二人民医院,云南昆明650000

出　　处：《心血管病防治知识（学术版）》2014年第1期16-18,共3页Prevention and Treatment of Cardiovascular Disease

摘　　要：目的探讨经短效硝苯地平诊治有重度血压增高状况的脑出血病人的疗效。方法 2011年2月24日至2013年2月24日,我科接诊有重度血压增高状况的脑出血者60例,随机将60例有重度血压增高状况的脑出血人员分组:对照组(30例)与治疗组(30例),对对照组经依那普利诊疗,对治疗组经依那普利+短效硝苯地平片诊疗,之后,比较对照组与治疗组的疗效。结果对照组与治疗组的治疗后状况与治疗前状况差异显著,P<0.05,比较对照组与治疗组的治疗效果,治疗组的疗效比对照组好,P<0.05。治疗组的SBP及DBP状况优于对照组,P<0.05。结论经短效硝苯地平片对存有重度血压增高状况的脑出血患者进行诊疗,不仅方便,而且疗效好、耐受性好,值得临床推广。Objective To investigate the clinical efficacy of short-acting nifedipine in cerebral hemorrhage patients with severely increased blood pressure. Methods Sixty cerebral hemorrhage patients with severely increased blood pressure, who were admitted to our department from February 24, 2011 to February 24, 2013, were randomly divided into control group （n=30） and treatment group （n=30）. The control group received enalapril, while the treatment group received enalapril combined with short-acting nifedipine tablets. The treatment outcomes of the two groups were compared. Results After treatment, both groups showed significant improvements （P〈0.05）; the treatment group bad a significantly better treatment outcome than the control group （P〈0.05）. The treatment group was superior to the control group in terms of systolic blood pressure and diastolic blood pressure （P〈0.05）. Conclusion Short-acting nifedipine tablets have the advantages of easy use, good efficacy, and good tolerability in cerebral hemorrhage patients with severely increased blood pressure and hold promise for clinical application.

关 键 词：脑出血 重度血压增高 依那普利 硝苯地平 疗效 临床推广 

分 类 号：R743.34[医药卫生—神经病学与精神病学]